---
title: "Hengrui Medicine Gets Nod for Chronic Kidney Disease Drug Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278525391.md"
description: "Hengrui Medicine Gets Nod for Chronic Kidney Disease Drug Trial"
datetime: "2026-03-10T09:25:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278525391.md)
  - [en](https://longbridge.com/en/news/278525391.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278525391.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/278525391.md) | [繁體中文](https://longbridge.com/zh-HK/news/278525391.md)


# Hengrui Medicine Gets Nod for Chronic Kidney Disease Drug Trial

Hengrui Medicine Gets Nod for Chronic Kidney Disease Drug Trial

### Related Stocks

- [Hengrui Pharma (600276.CN)](https://longbridge.com/en/quote/600276.CN.md)
- [HENGRUI PHARMA (01276.HK)](https://longbridge.com/en/quote/01276.HK.md)

## Related News & Research

- [Hengrui Pharmaceuticals Obtains Nod for Lung Cancer Combo Drug Trials](https://longbridge.com/en/news/277871128.md)
- [Hengrui Pharmaceuticals Gets Clinical Trial Nod for Hypertension Drug](https://longbridge.com/en/news/277870666.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/en/news/278010381.md)
- [Hutchmed to Withdraw Cancer Drug in China](https://longbridge.com/en/news/278378041.md)
- [Genedrive shareholders back fundraising as company expands pharmacogenetic footprint](https://longbridge.com/en/news/278383713.md)